Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed. Many patients with malignancy, a high-risk group, have recently had the first dose of the vaccine. A 75-year-old male with prostate cancer and biochemical recurrence underwent [18F]Choline PET/CT for disease assessment. No choline avid malignancy was identified; however, avid left axillary nodes were noted.
[18F]Choline PET/CT, maximal intensity projection (MIP)-A, demonstrates mild ill-defined uptake in the left arm (orange arrow) and areas of intense focal uptake in the left axilla (blue arrow). Tracer injection was via the right (contralateral) antecubital fossa, hence not a potential cause. The mildly avid symmetrical small volume mediastinal and hilar nodes are a common benign finding [1]. Axial CT, [18F]Choline PET, and fused [18F]Choline PET/CT of the chest (B, C, D) demonstrate uptake within level I/II left axillary nodes. Coronal CT, [18F]Choline PET, and fused [18F]Choline PET/CT of the left upper arm demonstrate uptake within the deltoid muscle (E, F, G).
The patient gave a history of receiving the Oxford-AstraZeneca covid-19 vaccination in the left upper arm 3 days earlier. An uptake in the left upper arm (deltoid) is in keeping with this. Clinical correlation supports the nodal uptake to be reactive, related to the recent vaccination. Similar findings were recently described with Pfizer-BioNTech COVID-19 vaccination but on [18F]FDG-PET/CT [2].
This case introduces a new PET/CT pitfall associated with the current COVID-19 pandemic vaccination programs on [18F]Choline, which if not made aware of, may result in incorrect image interpretation and inadvertent upstaging of disease.
References
Calabria F, Chiaravalloti A, Schillaci O. 18F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. Clin Nucl Med. 2014;39:122–30.
Eifer M, Eshet Y. Imaging of COVID-19 vaccination at FDG PET/CT. Radiology. 2021;210030.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and informed consent
All procedures performed involving the human participant were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the patient.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the month
Rights and permissions
About this article
Cite this article
Nawwar, A.A., Searle, J., Singh, R. et al. Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding. Eur J Nucl Med Mol Imaging 48, 2657–2658 (2021). https://doi.org/10.1007/s00259-021-05279-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-021-05279-2